Galectin-8, a predominantlty expressed bi-CDR galectin in human tumors with putative differential diagnostic applications

MARIA T. ELOLA, FATIMA FERRAGUT, VICTOR M. CARDENAS DELGADO, LORENA G. NUGNES, LUCAS GENTILINI, DIEGO LADERACH, MARIA F. TRONCOSO, DANIEL COMPAGNO, CARLOTA WOLFENSTEIN-TODEL AND GABRIEL A. RABINOVICH.

HISTOLOGY AND HISTOPATHOLOGY

F HERNANDEZ

Año: 2014 vol. 29 p. 1093 - 1105

0213-3911

Galectin-8 (Gal-8) is a ?tandem-repeat?-type galectin, which possesses two carbohydrate recognition domains connected by a linker peptide. Gal-8 complexity is related to the alternative splicing of its mRNA precursor, which is known to generate isoforms. Regarding its carbohydrate-binding specificity, Gal-8 has a unique feature among galectins, since its C-terminal domain has higher affinity for N-glycan-type branched oligosaccharides, while its N-terminal domain shows strong affinity for a2-3-sialylated or 3´-sulfated b-galactosides. We integrate here the available information on Gal-8 expression in different tumor types and attempt to elucidate associations of its expression and localization with tumor progression with the overarching goal of analyzing its potential applications in diagnosis and prognosis. Differential diagnosis is still a prime concern in tumor pathology, and Gal-8 could be of great value in some types of primary or secondary tumors (i.e. papillary thyroid carcinoma, advanced colon carcinoma from patients with distant metastases, or metastases from primary lung carcinoma). The prognostic value of Gal-8 has been described for laryngeal carcinoma as well as advanced colon carcinoma. Further studies are needed to explain the relevance of Gal-8 and its isoforms in tumor pathology and their different intra- or extracellular roles (cytoplasmic, nuclear or extracellular) in tumor biology.